Related Experiment Video

Updated: Sep 21, 2026

Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line
08:07

Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line

Published on: February 17, 2016

Selective stimulation of somatostatin receptor subtypes: differential effects on Ras/MAP kinase pathway and cell

M G Cattaneo1, J E Taylor, M D Culler

  • 1Department of Pharmacology, University of Milano, Via Vanvitell 32, 20129 Milan, Italy.

FEBS Letters
|September 29, 2000
PubMed

Insights

Somatostatin (SST) analogs inhibit cell division by distinct pathways. Selective SSTR1 or SSTR2 activation inhibits proliferation, while Ras inhibition requires combined SSTR2/SSTR5 stimulation, indicating a Ras-independent pathway for cell division inhibition.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Somatostatin (SST) is known to inhibit cell division, mitogen-activated protein (MAP) kinase, and Ras activity in human neuroblastoma cells.
  • Understanding the specific roles of different somatostatin receptor subtypes (SSTRs) is crucial for elucidating SST signaling pathways.

Purpose of the Study:

  • To investigate the effects of various somatostatin analogs, selective for SSTR1, SSTR2, or SSTR5, on cellular events.
  • To determine the specific receptor pathways involved in somatostatin's inhibition of cell proliferation, MAP kinase, and Ras activity.

Main Methods:

  • Utilized a series of somatostatin analogs with selectivity for SSTR1, SSTR2, and SSTR5.
  • Assessed the impact of these analogs on forskolin-induced cAMP accumulation, platelet-derived growth factor (PDGF)-induced [(3)H]thymidine incorporation, MAP kinase activity, and Ras activity in SY5Y cells.

Main Results:

  • All tested analogs inhibited forskolin-induced cAMP accumulation.
  • Selective stimulation of SSTR1 or SSTR2, but not SSTR5, inhibited PDGF-induced cell proliferation.
  • While all analogs inhibited early PDGF-stimulated MAP kinase activity, only combined SSTR2 and SSTR5 stimulation inhibited Ras activity, suggesting potential receptor heterodimerization.

Conclusions:

  • Somatostatin inhibits Ras and MAP kinase activities through distinct signaling pathways.
  • The inhibition of PDGF-induced cell proliferation by somatostatin occurs via a Ras-independent pathway, highlighting the complexity of SST signaling in neuroblastoma cells.

More Related Videos

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment07:55

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment

Published on: September 25, 2017

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening05:54

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...